LINC00963 and prostate carcinoma: Recently, LINC00963, a novel lncRNA, has been reported to be involved in the development of several tumors, such as breast cancer, ovarian tumors, esophageal tumors, cutaneous carcinoma, melanoma, hepatocellular carcinoma and prostate cancer [31–37].